新聞Genosity acquires Ciitizen.In October 2020, it bought ArcherDX Inc., in February 2021 bought microbiome sequencing company One Codex, two months later acquired genomic laboratory services company Genosity Inc. and last September bought Ciitizen Corp., a health technology company.
新聞Genosity partners with Invitae Corp.Genosity has already worked with Invitae on a number of projects and clinical research trials in the past.
新聞Invitae Corp acquired Genosity for $200M on Apr 5th '21.Under the terms of the agreement, Invitae will acquire Genosity for approximately $200 million, consisting of (i) approximately $120 million in cash and (ii) approximately $80 million in shares of Invitae common stock (based upon a trailing average closing price prior to the date of closing but subject to certain potential adjustments), with such stock and cash consideration subject to reduction based upon certain debt and transaction expenses of Genosity determined at closing.
